Snussing Out COVID
Swedish researchers have joined the growing body of people investigating whether nicotine (in the form of snus) can help mitigate the symptoms of COVID-19
-
by Dave Cross
Share on:
Last year, Mark Oates of the New Nicotine Alliance spoke about the proven benefit for snus to be used as a harm reduction tool. He was referring to it combating the blight of tobacco-related harm at the time, but it appears the same could be said for the coronavirus.
Snus is a moist powder smokeless product originating from a dry snuff in the early 18th-century. Tobacco-free variants are now available but it remains banned for sale in Europe despite the striking impact it has had on smoking rates where it is used.
The theory that nicotine might be acting in an anti-inflammatory way was first highlighted by Dr Konstantinos Farsalinos when he noticed that the rate of Chinese smokers being admitted to hospital with severe COVID symptoms was far below what would otherwise be expected.
Farsalinos, Niaura, and Poulas, wrote: “On 3 April, we were the first to establish the hypothesis that nicotine may be beneficial for COVID-19 patients and should be evaluated in clinical trials due to its anti-inflammatory properties. While in many cases the disease is mild, severe COVID-19 involves a hyper-inflammatory response, commonly called cytokine storm. This is characterized by the release of pro-inflammatory cytokines that can lead to Acute Respiratory Distress Syndrome and death.”
Then, in France, similar admission rates were observed by Jean-Pierre Changeux at the Pitié Salpétrière hospital. Changeux’s team announced plans to launch a clinical trial using nicotine patches.
The French researchers contacted Cecilia Magnusson, who works at the Centre for Epidemiology and Community Medicine in Sweden.
“Sweden has a unique opportunity because we are alone in having such widespread use of snus,” she told a national newspaper. “One could imagine that nicotine could be used as a treatment at covid-19.”
Cecilia Magnusson has co-authored a number of snus studies including one that showed non-smoking men used snus had “a substantially lower risk of Parkinson’s disease”.
“Sweden has already saved thousands of lives thanks to Swedish snus giving people a safer alternative to smoking cigarettes. Let’s hope Sweden can once again seize the opportunity for snus to contribute to reducing the harm associated with Covid-19.”
“Sweden is in a unique position due to its use of snus and it could well lead to a number of lives being saved around the world.”
Related:
- EU For Snus – [link]
- EU For Snus Twitter – [link]
- New Nicotine Alliance – [link]
- “Targeting the “Cytokine Storm” for Therapeutic Benefit” by D'Elia, Harrison, Oyston, Lukaszewski, and Clark – [link]
- “A contribution to the hypothesis of nicotinic challenge as therapeutic option for COVID-19 patients” by Manni, Tieri, and Soligo – [link]
- “COVID-19, a disease of the nicotinic cholinergic system? Nicotine may be protective” by Farsalinos, Niaura, and Poulas – [link]
- “Smoking Increases COVID-19 Risk... Right?” by Jason Kidde – [link]
- “La nicotine, une arme contre le Covid?”, France Inter – [link]
- Forskarnas teori: Svenskt snus skyddar mot corona – [link]
- Forskare: Snus kan skydda mot corona – [link]
Dave Cross
Journalist at POTVDave is a freelance writer; with articles on music, motorbikes, football, pop-science, vaping and tobacco harm reduction in Sounds, Melody Maker, UBG, AWoL, Bike, When Saturday Comes, Vape News Magazine, and syndicated across the Johnston Press group. He was published in an anthology of “Greatest Football Writing”, but still believes this was a mistake. Dave contributes sketches to comedy shows and used to co-host a radio sketch show. He’s worked with numerous vape companies to develop content for their websites.
Join the discussion
Harm Reduction For The Rich
The United Kingdom risks becoming a harm reduction country only for the wealthy, according to Michael Landl of the World Vapers’ Alliance
-
by Dave Cross
CAPHRA Highlights Tobacco Control Flaws
The Coalition of Asia Pacific Tobacco Harm Reduction Advocates highlights the flaws in tobacco control which has led to the rise of black market in Australia
-
by Dave Cross
A Missed Opportunity at COP10
The Smoke Free Sweden movement says that COP10 was a missed opportunity to save millions of lives
-
by Dave Cross
COP10: Promote Tobacco Harm Reduction
Experts with Smoke Free Sweden are emphasising the urgent need for a Tobacco Harm Reduction approach at COP10
-
by Dave Cross
